ReviewCurrent oncology (Toronto, Ont.)2026
Circulating Tumor DNA (ctDNA) for Minimal Residual Disease (MRD) Detection in Colorectal Cancer (CRC): Current Evidence, Clinical Applications, and Future Directions.
Hannah Hyde et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.